TMR Analyzes Impact of Outbreak of COVID-19 on Acute Respiratory Distress Syndrome Devices Market

Acute respiratory distress syndrome (ARDS) is a lethal respiratory disease, wherein lungs cannot adequately deliver oxygen to the vital body organs. Pneumonia, acute pancreatitis, inhalation of smoke, or chemicals and certain conditions could result in inflammation of lungs. Due to inflammation of lungs, fluid from surrounding blood vessels enter the air sacks of the lungs, resulting in difficulty in breathing. This condition is known as acute respiratory distress syndrome or ARDS.

Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=43673

The global acute respiratory distress syndrome devices market is primarily driven by increase in number of cases of ARDS, rise in diagnosis and treatment rates, surge in awareness about ARDS, and improvement in health care infrastructure. However, high cost of diagnostic and therapeutic devices and stringent regulatory landscape are likely to restrain the global acute respiratory distress syndrome devices market during the forecast period. Increase in R&D spending, technological advancements, and government initiatives to educate people about ARDS are expected to boost the growth of the global market.

Request a Sample of Acute Respiratory Distress Syndrome Devices Market: https://www.transparencymarketresearch.com/checkout.php?rep_id=43673<ype=S

Based on device type, the global acute respiratory distress syndrome devices market can be segmented into therapeutic devices and diagnostic & monitoring devices. The therapeutic devices segment can be categorized into mechanical ventilators, drug delivery devices, PAP, and others. The same market is further classified into non-invasive ventilator and invasive ventilator, by mechanical ventilators. In terms of drug delivery, the market can be bifurcated into nebulizers and humidifiers. In addition, the ARDS devices market has been categorized into devices and disposables sub-segments. The diagnostic & monitoring devices segment can be divided into pulse oximeters, spirometers, capnography devices, blood gas analyzers, and others. Based on end-user, the market can be classified into hospitals, independent clinics, and others.

Request for Analysis of COVID19 Impact on Acute Respiratory Distress Syndrome Devices Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=43673

Geographically, the global acute respiratory distress syndrome devices market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Around 60 in 100,000 people, or 150,000 people per year, suffer from ARDS and 70,000 people succumb to the disease in the U.S. each year. Over 50 people in 100,000 are affected by ARDS and 15 in 100,000 per year die from ARDS in Canada. The ARDS scenario in Western Europe is similar to North America. Around 60 in 100,000 people per year suffer from ARDS in Western Europe (the U.K., Germany, France, Spain, and Italy), whereas over 70 in 100,000 people per year suffer from ARDS in Eastern Europe (Romania, Bulgaria, Hungary, Poland, and Russia). However, North America and Europe held major market shares in 2017. The share of ARDS market in those two countries are anticipated to project by significant growth rates during the forecast period, owing to increase in number of ARDS cases in the regions, high diagnosis and treatment rates of ARDS, strong health care infrastructure, and favorable health care reimbursement. Incidence of ARDS is low in Asia Pacific. Around 45 in 100,000 people per year suffer from ARDS in the region. Asia Pacific is projected to account for the third largest market share in 2017. The market in the region is anticipated to expand at the fastest CAGR during the forecast period due to large population developing health care infrastructure, participation of domestic players, and presence of market leaders. Low diagnosis and treatment rates of ARDS, less awareness about ARDS, and inadequate health care infrastructure are likely to restrain the ARDS devices market in Latin America and Middle East & Africa during the forecast period.

Pre-Book Acute Respiratory Distress Syndrome Devices Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=43673<ype=S

Key players in the global acute respiratory distress syndrome devices market are ResMed, Phillips, GE Healthcare, Hamilton Medical AG, Masimo Corporation, Nonin Medical, BPL Medical Technologies, Smiths Medical, and Beurer GmbH, among others.

Read More Reports: https://www.prnewswire.com/news-releases/empty-capsules-market-to-ride-the-wave-of-increasing-focus-on-preventive-healthcare-transparency-market-research-301009692.html

Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com/

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

This release was published on openPR.